Tuesday afternoon, the House of Representatives voted in favor of a spending bill that includes major pharmacy benefit manager (PBM) reforms aimed at increasing price transparency for consumers and ...

Medicare programs and policies can change each year, which means you'll need to review all of your options before you enroll. If you're new to Medicare, the health insurance landscape can seem ...

Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...

Federal officials have a plan that could curb billions of dollars in overpayments to Medicare Advantage plans. But will they ...

For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, ...

Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price negotiations that could lower prices for Medicare patients.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower prices expected in 2028.

CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The Centers for Medicare & Medicaid Services (CMS) has released a proposal outlining 2027 payment and policy updates to Medicare.

Hospitals and health systems continue to sever ties with certain Medicare Advantage plans heading into 2026, citing persistent frustrations with prior authorization denials and slow reimbursement from ...